Erectile dysfunction and mental health in a general population of older men

Journal of Sexual Medicine

Volumn 6, Issue 2, 2009, Pages 505-512

  Korfage, Ida J ^a   Pluijm, Saskia ^a   Roobol, Monique ^a   Dohle, Gert R ^a   Schröder, Fritz H ^a   Essink Bot, Marie Louise ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aged; Erectile dysfunction; Male; Mental health; Urology

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROSTATE CANCER; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SHORT FORM 36;

EID: 59349112147     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01111.x     Document Type: Article

References (31)

1. Litwin MS. Health related quality of life in older men without prostate cancer. J Urol 1999;161:1180-4.
2. Korfage IJ, Roobol M, de Koning HJ, Kirkels WJ, Schroder FH, Essink-Bot ML. Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey. Urology 2008;72:3-9.
3. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ, Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006;166:207-12.
4. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2,869 men using a validated questionnaire. Eur Urol 2005;47:80-5; Discussion 5-6.
5. Blanker MH, Bosch JL, Groeneveld FP, Bohnen AM, Prins A, Thomas S, Hop WC. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: Prevalence, concern, and relation to sexual activity. Urology 2001;57:763-8.
6. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL. Prevalence of erectile dysfunction: A systematic review of population-based studies. Int J Impot Res 2002;14:422-32.
7. Derogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med 2008;5:289-300.
8. De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Pellegrini F, Sacco M, Tognoni G, Valentini M, Nicolucci A. Erectile dysfunction and quality of life in type 2 diabetic patients: A serious problem too often overlooked. Diabetes Care 2002;25:284-91.
9. Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser DB, Feldman HI. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int 2003;64:232-8.
10. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol 2003;44:245-53.
11. Abdo CH, Oliveira WM Jr, Scanavino Mde T, Martins FG. [Erectile dysfunction: Results of the Brazilian Sexual Life Study]. Disfuncao eretil: Resultados do Estudo da Vida Sexual do Brasileiro. Rev Assoc Med Bras 2006;52:424-9.
12. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997;9:141-8.
13. Giuliano F, Pena BM, Mishra A, Smith MD. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res 2001;10:359-69.
14. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:1773-85.
15. Gheorghiu S, Godschalk M, Gentili A, Mulligan T. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction. J Urol 1996;156:80-1.
16. Gralla O, Knoll N, Fenske S, Spivak I, Hoffmann M, Ronnebeck C, Lenk S, Hoschke B, May M. Worry, desire, and sexual satisfaction and their association with severity of ED and age. J Sex Med 2008 [Epub ahead of print].
17. Laumann EO, Waite LJ. Sexual dysfunction among older adults: Prevalence and risk factors from a nationally representative U.S. probability sample of men and women 57-85 years of age. J Sex Med 2008 [Epub ahead of print].
18. Roobol MJ, Kirkels WJ, Schroder FH. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands). BJU Int 2003;92(suppl 2):48-54.
19. Ware JEJ, Snow KK, Kosinski M, Gandek BG. SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
20. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582-92.
21. Slob AK, Blom JH, van der Werff ten Bosch JJ. Erection problems in medical practice: Differential diagnosis with relatively simple method. J Urol 1990;143:46-50.
22. Korfage IJ, Essink-Bot ML, Madalinska JB, Kirkels WJ, Litwin MS, de Koning HJ. Measuring disease specific quality of life in localized prostate cancer: The Dutch experience. Qual Life Res 2003;12:459-64.
23. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: From the male attitudes regarding sexual health survey. J Sex Med 2007;4:57-65.
24. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
25. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
26. Hoffman RM, Stone SN, Espey D, Potosky AL. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer 2005;5:27-35.
27. Otto SJ, Schroder FH, de Koning HJ. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. J Clin Oncol 2006;24:4184-9.
28. Cronin KA, Weed DL, Connor RJ, Prorok PC. Case-control studies of cancer screening: Theory and practice. J Natl Cancer Inst 1998;90:498-504.
29. Willke RJ, Yen W, Parkerson GR Jr, Linet OI, Erder MH, Glick HA. Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and South Africa. Int J Impot Res 1998;10:239-46.
30. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Longitudinal differences in psychological outcomes for men with erectile dysfunction: Results from ExCEED. J Sex Med 2006;3:1068-76.
31. Korfage IJ, Hak T, de Koning HJ, Essink-Bot ML. Patients' perceptions of the side-effects of prostate cancer treatment - a qualitative interview study. Soc Sci Med 2006;63:911-9.